New vaccine trial on the way
 

Dr. Albert Deisseroth, president and CEO for the Sidney Kimmel Cancer Center, San Diego:

"Clinical testing will begin next spring on a vaccine for treating breast cancer. The vaccine, which has been in development for more than five years, works by activating the body's immune system to suppress the recurrence of breast cancer following initial surgery. The process initiates an immune response against a self-antigen known as MUC-1. The antigen exhibits altered structure and expression in breast cancer. Injection of this vaccine under the skin can provide up to one year's resistance against the growth of cancer cells. The vaccine may be effective against other forms of cancer as well."

The clinical testing will begin in a few months in part to a $250,000 grant from the Breast Cancer Research Foundation.

ProfNet
Ste 200, 888 Veterans Highway
Hauppauge, NY 11788
United States
profnet.com

Quick Question
 

Do you have any idea what the criteria is in order to qualify for this study?

Eric, do you have any links to the article? I wonder what MUC is? They are talking in Seattle about maybe starting a booster vaccine trial , because like this says, i think in a year it can wear off

Thanks Eric,

If you can provide links to additional information it would be greatly appreciated.

Al